润贝航空科技股份有限公司 投资者关系活动记录表 证券代码：001316 证券简称：润贝航科 编号：2022-03 | --- | --- | --- | |----------|--------------------------|--------------------------------------------------------------------| | | | | | 投资者关 | 特定对象调研 | □分析师会议 | | 系活动类 | | □媒体采访 □业绩说明会 | | 别 | □新闻发布会 □路演活动 | | | | | □现场参观 □其他（电话会议） | | 参与单位 | 中欧瑞博 刘飞 | | | | | | | 名称及人 | 太平洋证券 | 马浩然 | | 员姓名 | | | | 时间 | 2022 年 11 月 22 | 日 | | 地点 | | 润贝航空科技股份有限公司会议室 | | 上市公司 | 董事会秘书：徐烁华 | | | 接待人员 | 副总经理：田野 | | | | 证券事务代表：陈晓宇 | | | 投资者关 | 一、 润贝航科简介环节 | | | 系活动主 | | ...

润贝航空科技股份有限公司 投资者关系活动记录表 证券代码：001316 证券简称：润贝航科 编号：2022-01 | --- | --- | --- | |----------|-----------------------------|--------------------------------------------------------------| | | | | | 投资者关 | 特定对象调研 | □分析师会议 | | 系活动类 | □媒体采访 □业绩说明会 | | | 别 | □新闻发布会 □路演活动 | | | | | □现场参观 □其他（电话会议） | | 参与单位 | 小忠资本：梁幸 | | | 名称及人 | 融投界：叶凯华 | | | 员姓名 | 赛硕基金：杨辉 | | | | 中广盛通投资：张本庚 | | | | 申万宏源证券：李军辉 | | | | 兴业证券：王帅 | | | 时间 | 2022 年 7 月 6 日 | | | 地点 | | 润贝航空科技股份有限公司会议室 | | 上市公司 | 副总经理：田野 | | | 接待人员 | 证券事务代表：陈晓宇 | | | 投资者关 ...

润贝航空科技股份有限公司 投资者关系活动记录表 证券代码：001316 证券简称：润贝航科 编号：2022-02 | --- | --- | --- | |----------|-------------------------------------|------------------------------------------------------------| | | | | | 投资者关 | 特定对象调研 | □分析师会议 | | 系活动类 | □媒体采访 □业绩说明会 | | | 别 | □新闻发布会 □路演活动 | | | | | □现场参观 □其他（电话会议） | | 参与单位 | 华福证券 魏征宇 | | | 名称及人 | 前海辰星投资 | 严冬冬 | | 员姓名 | 中邮证券 麦梓轩 | | | 时间 | 2022 年 9 月 27 日 | | | 地点 | | 润贝航空科技股份有限公司会议室 | | 上市公司 | 董事会秘书：徐烁华 | | | 接待人员 | 副总经理：田野 证券事务代表：陈晓宇 | | | 投资者关 | 一、 润贝航科简介环节 | | | 系活动主 | | | | ...

Financial Performance - The company's revenue for Q3 2022 was ¥156,234,683.85, representing a decrease of 2.60% compared to the same period last year[5] - Net profit attributable to shareholders for Q3 2022 was ¥14,739,193.84, down 36.78% year-on-year[5] - The basic earnings per share for Q3 2022 was ¥0.1456, a decline of 62.53% compared to the previous year[5] - The company reported a decrease in net profit excluding non-recurring items to ¥14,685,131.79, a decline of 20.49% compared to the same period last year[5] - Total revenue for the third quarter was CNY 405,275,427.69, a decrease of 22.4% compared to CNY 522,331,290.35 in the same period last year[25] - Net profit for Q3 2022 was CNY 59,928,669.32, a slight decrease from CNY 60,254,430.28 in Q3 2021, representing a decline of approximately 0.54%[27] - The company reported a net profit margin of approximately 15.8% for the quarter, reflecting improved cost management[25] Assets and Equity - Total assets as of September 30, 2022, reached ¥1,121,803,581.88, an increase of 92.61% from the end of the previous year[5] - Shareholders' equity attributable to the parent company was ¥1,033,018,593.63, up 116.94% from the previous year-end[5] - The company's total assets reached CNY 1,121,803,581.88, a significant increase from CNY 582,408,612.31, marking a growth of 92.5%[24] - The capital reserve increased to CNY 613,225,202.90 from CNY 160,145,004.79, reflecting a growth of 283.5%[24] Cash Flow and Operating Activities - The cash flow from operating activities showed a net outflow of ¥12,882,424.11, a decrease of 7.00% year-to-date[5] - The company reported a net cash flow from operating activities of CNY -12,882,424.11 for Q3 2022, compared to CNY -13,852,053.36 in the same period last year, indicating a slight improvement[31] - Cash and cash equivalents increased significantly to CNY 406,837,991.49 from CNY 212,889,177.67, representing an increase of 91.1%[22] - Cash and cash equivalents at the end of Q3 2022 increased to CNY 406,837,991.49, up from CNY 83,374,003.05 at the end of Q3 2021, showing a significant increase[32] Expenses and Liabilities - R&D expenses rose by 30.22% to ¥6,258,525.97, reflecting the company's increased investment in independent product development[16] - Financial expenses skyrocketed by 806.65% to ¥7,400,842.23, mainly due to increased foreign exchange losses[16] - Other current liabilities rose by 199.25% to ¥13,934,042.00, primarily due to increased intermediary issuance fees[13] - The company experienced a 73.29% decrease in taxes and surcharges to ¥344,114.97, linked to reduced revenue due to the impact of the pandemic[16] - The company reported a tax expense of CNY 13,280,111.52 for Q3 2022, down from CNY 15,726,010.06 in Q3 2021, indicating a decrease of approximately 15.5%[27] Investments and Growth - The company plans to expand its market presence and invest in new technologies to drive future growth[25] - The company received government subsidies amounting to ¥72,551.99 in Q3 2022, primarily related to R&D and employment stabilization[8] - The company reported a significant increase in capital reserves by 282.92% to ¥613,225,202.90, resulting from the completion of the IPO[13] - The company experienced a significant increase in cash outflow from investment activities, totaling CNY 530,624,034.70 in Q3 2022, compared to CNY 407,517,555.43 in Q3 2021[32] Shareholder Information - The number of ordinary shareholders reached 15,975, with the top ten shareholders holding a combined 75.08% of the shares[18]

Financial Performance - The company's operating revenue for the first half of 2022 was approximately ¥249.04 million, a decrease of 31.19% compared to ¥361.93 million in the same period last year[24]. - Net profit attributable to shareholders increased by 22.23% to approximately ¥45.28 million, up from ¥37.05 million in the previous year[24]. - The net cash flow from operating activities was negative at approximately -¥6.51 million, a decline of 249.98% compared to a positive cash flow of ¥4.34 million in the same period last year[24]. - Basic and diluted earnings per share rose by 20.97% to ¥0.75, compared to ¥0.62 in the previous year[24]. - The company's operating revenue for the current period is CNY 249,040,743.84, a decrease of 31.19% compared to CNY 361,928,300.71 in the same period last year, primarily due to the impact of COVID-19 on domestic flight numbers[55]. - The company's operating costs decreased by 32.04% to CNY 173,186,120.61, aligning with the reduction in revenue due to the pandemic[55]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was 34.63 million yuan, up 3.48% year-on-year[34]. - The company reported a significant improvement in credit impairment losses, with a loss of CNY 13,433,914.10 compared to a loss of CNY 24,980,740.31 in the previous year[166]. Assets and Liabilities - Total assets at the end of the reporting period reached approximately ¥1.10 billion, an increase of 89.70% from ¥582.41 million at the end of the previous year[24]. - Net assets attributable to shareholders increased by 110.90% to approximately ¥1.00 billion, compared to ¥476.18 million at the end of the previous year[24]. - The company's total assets as of June 30, 2022, amounted to CNY 876,878,931.88, significantly up from CNY 472,209,489.43 at the beginning of the year[160]. - The total current liabilities decreased to CNY 98,773,454.09 from CNY 103,185,651.98, showing a reduction of approximately 4%[156]. - The accounts receivable decreased by 17.54% to CNY 150,102,676.10, reflecting the impact of reduced operating revenue[66]. - The company's total liabilities decreased to CNY 97,573,411.61 from CNY 179,715,822.11, indicating a reduction of 45.7%[162]. Research and Development - Research and development investment increased by 5.02% to CNY 3,224,361.19, reflecting a greater focus on self-developed products[57]. - The R&D expenditure increased by 8.11% compared to the previous year, emphasizing the commitment to innovation[186]. - The company has committed a total investment of 476.08 million yuan in various projects, with no progress made on these investments as of the reporting date[81]. Market and Product Development - The company successfully launched its self-developed aviation disinfection series products, which began sales to non-aviation clients such as airports and financial institutions during the reporting period[33]. - The company is actively promoting the construction of a new production base for aviation non-metallic materials and composite materials[33]. - The company is focusing on the domestic market for aviation materials, especially with the upcoming commercial delivery of the C919 aircraft, which is expected to boost the demand for domestic aviation materials[37]. - The company is actively promoting domestic aviation material products to reduce reliance on imports, aligning with its dual-driven development strategy[43]. - The company plans to enhance supply chain management and service levels while increasing R&D investment to improve the competitiveness of self-developed aviation materials[88]. Shareholder and Equity Information - The company completed its initial public offering (IPO) with 20 million shares issued at a price of 29.20 RMB per share, listed on June 24, 2022[136]. - As of the end of the reporting period, the total number of ordinary shareholders was 28,838, with the largest shareholder holding 62.78% of the shares[138]. - The total number of shares after the IPO is 80 million, consisting of 60 million restricted shares and 20 million unrestricted shares[134]. - The largest shareholder, Shenzhen Jialun Investment Development Co., Ltd., holds 50,225,100 shares, representing 62.78% of the total shares[138]. - The company has not distributed cash dividends or bonus shares for the half-year period and has no plans for capital reserve conversion into share capital[97]. Operational Challenges and Strategies - The aviation material distribution business faced a significant decline in demand due to the pandemic, impacting overall sales revenue[45]. - The company will closely monitor the pandemic situation and adjust its operational strategies accordingly to mitigate potential impacts on performance[88]. - The company has a high supplier concentration risk, particularly with its main supplier of aviation lubricants, which could adversely affect operations if agreements are not renewed or terms change significantly[90]. - The company is actively monitoring foreign currency transactions and considering hedging strategies to mitigate foreign exchange risks[92]. Miscellaneous - The company has not disclosed any significant new product developments or market expansion strategies in this report[5]. - The company emphasizes the importance of risk awareness regarding forward-looking statements made in the report[5]. - There were no significant legal disputes or arbitration matters during the reporting period[110]. - The company has not engaged in any major related party transactions during the reporting period[113]. - The financial report was approved by the company's board of directors on August 19, 2022[200].